Bleeding disorders, vascular issues, or difficulty accessing veins may complicate IV therapy
It requires daily injections rather than weekly, which has reduced its use as semaglutide and tirzepatide have become available
At the end of the study period, the researchers found that there was no advantage at any point over the course of 96 weeks in the group using exenatide
Hence, they are an asset in developing new drugs or improving existing on-market therapeutics
It does not provide miraculous weight loss for inactive individuals
Biomed Pharmacother 162:114606 Jomova K, Alomar SY, Alwasel SH, Nepovimova E, Kuca K, Valko M (2024) Several lines of antioxidant defense against oxidative stress: antioxidant enzymes, nanomaterials with multiple enzyme-mimicking activities, and low-molecular-weight antioxidants